The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2016 | Building a clinical research platform to capture and leverage data from cancer care in Germany
Frank Griesinger, MD, PhD from the Pius-Hospital Oldenburg, Oldenburg, Germany discusses progress in the development of a German clinical research platform. The platform started a year ago and aims to prospectively capture in-depth data including clinical characteristics, health insurance, socio-economic factors, patient outcomes and quality of life. Around 10,000 patients were recruited into this registry which also include data from a bio bank and a tissue repository with clinically annotated material. According to Dr. Griesinger, this is a very important study that will allow to analyse how patients are treated in Germany, and to identify correlations between molecular, clinical and other socio-economic factors. Experts will also be able to correlate new biomarkers with clinical outcomes. Dr. Griesinger believes that future improvements will be apparent for treatment, diagnostics and access to clinical trials in Germany.
Recorded at the 2016 World Congress of Lung Cancer (WCLC) of the International Association for the Study of Lung Cancer (IASLC) in Vienna, Austria.
